Hill Holliday has promoted David Leonardi to chief creative officer of its healthcare practice, Hill Holliday Health. David will be reporting into Icaro Doria, North American chief creative officer at Hill Holliday. This is one of Icaro’s first executive moves, since joining Hill Holliday in January of 2021. David joined Hill Holliday Health as executive creative director in 2013 with over 15 years of experience on such consumer health brands as LIPITOR, Prevacid, SPIRIVA and LAP-BAND.
“Over the past decade, our healthcare expertise has grown quietly yet tremendously, driving results for some of the biggest names in the industry,” said Icaro. “David has been a huge part of that growth, I have full faith in his creative vision, his goals for further growth, and I look forward to working with him to create brave, ambitious, and culturally relevant ideas for our health clients going forward.”
“I’m really looking forward to building on our success, and of course, I’m grateful for the opportunity to work alongside Icaro - an amazing creative leader and person - to help him create the next chapter in Hill Holliday’s storied history." added David. "There’s an intangible quality and commitment with everyone here at Hill Holliday Health; our collective passion to help people is real. We use every ounce of that to create work that breaks through, builds client business and helps change - or even save - lives."
Hill Holliday Health has experienced impressive growth after launching its healthcare practice bringing on four new client companies and seven new brands in CNS, oncology, women’s healthcare and ophthalmology, and was recently ranked #28 on Medical Marketing and Media’s Top 100 Health Agencies and revenue grew 32% to an MM+M-estimated $70 million in 2020. Hill Holliday Health’s clients include J&J, Lundbeck, Regeneron and Intra-Cellular Therapies amongst some of the biggest brands in healthcare.